TrimRX
US$ 28.92
triple hormone receptor agonist retatrutide Medscape | Retatrutide, Eli Lilly's first-in-class agonist, delivered meaningful weight loss at 80 weeks in all doses in the Achieve Your Weight Loss Goals
Description
Important contraindications include uncontrolled hypertension, a history of seizure disorders, and current or recent use of opioid medicines
With that said, their rapid rise in use has prompted increased scrutiny, and their status is an area to monitor as scientific understanding and usage patterns continue to evolve.
doi: 10.1172/JCI57256 [DOI] [PMC free article] [PubMed] [Google Scholar] 225
Triglycerides deserve particular attention in this discussion
